Scholar Rock Holding Corporation

NasdaqGS:SRRK Stock Report

Market Cap: US$1.1b

Scholar Rock Holding Past Earnings Performance

Past criteria checks 0/6

Scholar Rock Holding's earnings have been declining at an average annual rate of -26.2%, while the Biotechs industry saw earnings growing at 12.7% annually. Revenues have been growing at an average rate of 4.5% per year.

Key information

-26.2%

Earnings growth rate

-4.1%

EPS growth rate

Biotechs Industry Growth17.0%
Revenue growth rate4.5%
Return on equity-73.6%
Net Marginn/a
Last Earnings Update31 Dec 2023

Recent past performance updates

Recent updates

Scholar Rock: Solid Data And Good Prospects

Jan 12

Scholar Rock Holding Corporation's (NASDAQ:SRRK) Share Price Not Quite Adding Up

Apr 19
Scholar Rock Holding Corporation's (NASDAQ:SRRK) Share Price Not Quite Adding Up

Scholar Rock: OLE Data In SMA Coupled With New CEO Make It A Buy

Oct 20

Jay Backstrom is the new CEO at Scholar Rock

Sep 20

Scholar Rock initiated at buy at Truist on platform for rare diseases and oncology

Jul 12

Brokers Are Upgrading Their Views On Scholar Rock Holding Corporation (NASDAQ:SRRK) With These New Forecasts

May 21
Brokers Are Upgrading Their Views On Scholar Rock Holding Corporation (NASDAQ:SRRK) With These New Forecasts

Broker Revenue Forecasts For Scholar Rock Holding Corporation (NASDAQ:SRRK) Are Surging Higher

Mar 08
Broker Revenue Forecasts For Scholar Rock Holding Corporation (NASDAQ:SRRK) Are Surging Higher

Scholar Rock Holding Corporation (NASDAQ:SRRK) Analysts Are More Bearish Than They Used To Be

May 15
Scholar Rock Holding Corporation (NASDAQ:SRRK) Analysts Are More Bearish Than They Used To Be

Is Scholar Rock Holding (NASDAQ:SRRK) Using Too Much Debt?

May 07
Is Scholar Rock Holding (NASDAQ:SRRK) Using Too Much Debt?

If You Had Bought Scholar Rock Holding (NASDAQ:SRRK) Stock A Year Ago, You Could Pocket A 283% Gain Today

Mar 01
If You Had Bought Scholar Rock Holding (NASDAQ:SRRK) Stock A Year Ago, You Could Pocket A 283% Gain Today

We Think Scholar Rock Holding (NASDAQ:SRRK) Can Afford To Drive Business Growth

Jan 05
We Think Scholar Rock Holding (NASDAQ:SRRK) Can Afford To Drive Business Growth

Scholar Rock EPS misses by $0.23, misses on revenue

Nov 09

Scholar Rock Is At Phase 2, $1 Billion Is Too Expensive

Nov 04

Scholar Rock prices ~$200M equity offering.

Oct 29

Revenue & Expenses Breakdown
Beta

How Scholar Rock Holding makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

NasdaqGS:SRRK Revenue, expenses and earnings (USD Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
31 Dec 230-166490
30 Sep 230-159470
30 Jun 230-160440
31 Mar 230-166430
31 Dec 2233-135430
30 Sep 2237-131430
30 Jun 2243-125430
31 Mar 2247-112420
31 Dec 2119-132400
30 Sep 2118-122380
30 Jun 2116-109350
31 Mar 2115-97320
31 Dec 2015-86280
30 Sep 2020-71260
30 Jun 2021-64240
31 Mar 2022-57230
31 Dec 1920-51210
30 Sep 1913-54200
30 Jun 198-49170
31 Mar 193-51160
31 Dec 180-49140
30 Sep 180-43110
30 Jun 180-3890
31 Mar 180-2960
31 Dec 170-2550
31 Dec 160-1640

Quality Earnings: SRRK is currently unprofitable.

Growing Profit Margin: SRRK is currently unprofitable.


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: SRRK is unprofitable, and losses have increased over the past 5 years at a rate of 26.2% per year.

Accelerating Growth: Unable to compare SRRK's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: SRRK is unprofitable, making it difficult to compare its past year earnings growth to the Biotechs industry (-8.9%).


Return on Equity

High ROE: SRRK has a negative Return on Equity (-73.61%), as it is currently unprofitable.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.